Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Pneumothorax
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Cause== [[File:Pneumot rax bullae.JPG|thumb|upright=1.2|alt=A schematic drawing showing a bulla and a bleb, two lung abnormalities that can lead to pneumothorax |A schematic drawing of a bulla and a bleb, two lung abnormalities that may rupture and lead to pneumothorax]] ===Primary spontaneous=== Spontaneous pneumothoraces are divided into two types: ''primary'', which occurs in the absence of known lung disease, and ''secondary'', which occurs in someone with underlying lung disease.<ref name="Lyra">{{cite journal | vauthors = Lyra RD | title = Etiology of primary spontaneous pneumothorax | journal = Jornal Brasileiro de Pneumologia | volume = 42 | issue = 3 | pages = 222–226 | date = May–June 2016 | pmid = 27383937 | pmc = 5569604 | doi = 10.1590/S1806-37562015000000230 }}</ref> The cause of primary spontaneous pneumothorax is unknown, but established risk factors include being of the male sex, [[smoking]], and a [[family history (medicine)|family history]] of pneumothorax.<ref name=Rosen2010/> Smoking either [[cannabis]] or [[tobacco]] increases the risk.<ref name=BMJ2014/> The various suspected underlying mechanisms are discussed [[#Mechanism|below]].<ref name=Tschopp/><ref name=Noppen/> ===Secondary spontaneous=== Secondary spontaneous pneumothorax occurs in the setting of a variety of lung diseases. The most common is [[chronic obstructive pulmonary disease]] (COPD), which accounts for approximately 70% of cases.<ref name=Rosen2010/> The following known lung diseases may significantly increase the risk for pneumothorax. {| class="wikitable" ! scope="col" | Type ! scope="col" | Causes |- ! scope="row" | Diseases of the airways<ref name=Tschopp/> | COPD (especially when [[bullous emphysema]] is present), [[asthma|acute severe asthma]], [[cystic fibrosis]] |- ! scope="row" | Infections of the lung<ref name=Tschopp/> | [[Pneumocystis pneumonia]] (PCP), [[tuberculosis]], [[pneumonia|necrotizing pneumonia]] |- ! scope="row" | [[Interstitial lung disease]]<ref name=Tschopp/> | [[Sarcoidosis]], [[idiopathic pulmonary fibrosis]], [[Langerhans cell histiocytosis|histiocytosis X]], [[lymphangioleiomyomatosis]] (LAM) |- ! scope="row" | [[Connective tissue disease]]s<ref name=Tschopp/> | [[Rheumatoid arthritis]], [[ankylosing spondylitis]], [[polymyositis]] and [[dermatomyositis]], [[systemic sclerosis]], [[Marfan's syndrome]] and [[Ehlers–Danlos syndrome]] |- ! scope="row" | [[Cancer]]<ref name=Tschopp/> | [[Lung cancer]], [[sarcoma]]s involving the lung |- ! scope="row" | Miscellaneous<ref name=Noppen/> | [[Catamenial pneumothorax]] (associated with the [[menstrual cycle]] and related to [[endometriosis]] in the chest) |} In children, additional causes include [[measles]], [[echinococcosis]], inhalation of a [[foreign body]], and certain [[congenital malformation]]s ([[congenital pulmonary airway malformation]] and [[Pneumatosis#Congenital lobar emphysema|congenital lobar emphysema]]).<ref name="Robinson">{{cite journal | vauthors = Robinson PD, Cooper P, Ranganathan SC | title = Evidence-based management of paediatric primary spontaneous pneumothorax | journal = Paediatric Respiratory Reviews | volume = 10 | issue = 3 | pages = 110–7; quiz 117 | date = September 2009 | pmid = 19651381 | doi = 10.1016/j.prrv.2008.12.003 }}</ref> 11.5% of people with a spontaneous pneumothorax have a family member who has previously experienced a pneumothorax. Several hereditary conditions – [[Marfan syndrome]], [[homocystinuria]], [[Ehlers–Danlos syndromes]], [[alpha 1-antitrypsin deficiency]] (which leads to [[Pneumatosis#Lungs|emphysema]]), and [[Birt–Hogg–Dubé syndrome]] – have all been linked to familial pneumothorax.<ref name="Chiu">{{cite journal | vauthors = Chiu HT, Garcia CK | title = Familial spontaneous pneumothorax | journal = Current Opinion in Pulmonary Medicine | volume = 12 | issue = 4 | pages = 268–272 | date = July 2006 | pmid = 16825879 | doi = 10.1097/01.mcp.0000230630.73139.f0 | s2cid = 45908721 }}</ref> Generally, these conditions cause other signs and symptoms as well, and pneumothorax is not usually the primary finding.<ref name=Chiu/> Birt–Hogg–Dubé syndrome is caused by mutations in the ''FLCN'' [[gene]] (located at [[chromosome 17]]p11.2), which encodes a protein named [[folliculin]].<ref name=Robinson/><ref name=Chiu/> ''FLCN'' mutations and lung lesions have also been identified in familial cases of pneumothorax where other features of Birt–Hogg–Dubé syndrome are absent.<ref name=Robinson/> In addition to the genetic associations, the [[human leukocyte antigen|HLA]] [[haplotype]] A<sub>2</sub>B<sub>40</sub> is also a genetic predisposition to PSP.<ref name="Fishman1520">{{Cite book |vauthors=Levine DJ, Sako EY, Peters J | title=Fishman's Pulmonary Diseases and Disorders |url=https://archive.org/details/fishmanspulmonar00afis |url-access=limited | publisher=McGraw-Hill | year=2008 | page=[https://archive.org/details/fishmanspulmonar00afis/page/n1551 1520] | edition=4th | isbn=978-0-07-145739-2 }}</ref><ref name="Light307">{{Cite book | vauthors = Light RW | title=Pleural diseases | publisher=Lippincott Williams & Wilkins | year=2007 | page=307 | edition=5th | isbn=978-0-7817-6957-0 }}</ref> ===Traumatic=== A traumatic pneumothorax may result from either [[blunt trauma]] or [[Penetrating trauma|penetrating injury]] to the chest wall.<ref name=Noppen/> The most common mechanism is the penetration of sharp bony points at a new [[rib fracture]], which damages lung tissue.<ref name=Rosen2010>{{cite book |title=Rosen's emergency medicine: concepts and clinical practice |edition=7th | vauthors = Marx J |year=2010 |publisher=Mosby/Elsevier |location=Philadelphia, PA |isbn=978-0-323-05472-0 |pages=393–96}}</ref> Traumatic pneumothorax may also be observed in those [[blast injury|exposed to blasts]], even when there is no apparent injury to the chest.<ref name=Wolf2009/> Traumatic pneumothoraces may be classified as "open" or "closed". In an open pneumothorax, there is a passage from the external environment into the pleural space through the chest wall. When air is drawn into the pleural space through this passageway, it is known as a "sucking chest wound". A closed pneumothorax is when the chest wall remains intact.<ref name="Rathert">{{cite web|vauthors = ((Nicholas Rathert, W. Scott Gilmore, MD, EMT-P))|title=Treating Sucking Chest Wounds and Other Traumatic Chest Injuries|url=http://www.jems.com/articles/print/volume-38/issue-8/patient-care/treating-sucking-chest-wounds-and-other.html|website=www.jems.com|publisher=Journal of Emergency Medical Services|access-date=28 September 2017|archive-url=https://web.archive.org/web/20150408043836/http://www.jems.com/articles/print/volume-38/issue-8/patient-care/treating-sucking-chest-wounds-and-other.html|archive-date=8 April 2015|date=19 July 2013|url-status=dead}}</ref> Pneumothorax was reported as an adverse event caused by misplaced [[Nasogastric intubation|nasogastric feeding tubes]]. [[Avanos Medical]]'s feeding tube placement system, the CORTRAK* 2 EAS, was recalled in May 2022 by the [[Food and Drug Administration|FDA]] due to adverse events reported, including pneumothorax, leading to 60 injuries and 23 people dying as communicated by the FDA.<ref>{{cite web |title=Avanos Medical Recalls Cortrak*2 Enteral Access System for Risk of Misplaced Enteral Tubes Could Cause Patient Harm |url=https://www.fda.gov/medical-devices/medical-device-recalls/avanos-medical-recalls-cortrak2-enteral-access-system-risk-misplaced-enteral-tubes-could-cause |archive-url=https://web.archive.org/web/20220513213417/https://www.fda.gov/medical-devices/medical-device-recalls/avanos-medical-recalls-cortrak2-enteral-access-system-risk-misplaced-enteral-tubes-could-cause |url-status=dead |archive-date=13 May 2022 |website=FDA |date=16 May 2022 |publisher=Admin |access-date=16 May 2022}}</ref> Medical procedures, such as inserting a [[central venous catheter]] into one of the chest veins or taking [[biopsy]] samples from lung tissue, may also lead to pneumothorax. The administration of [[positive pressure ventilation]], either [[mechanical ventilation]] or [[non-invasive ventilation]], can result in [[barotrauma]] (pressure-related injury) leading to a pneumothorax.<ref name=Noppen/> [[Underwater diving|Divers]] who breathe from an underwater apparatus are supplied with breathing gas at [[ambient pressure]], which results in their lungs containing gas at higher than atmospheric pressure. Divers breathing compressed air (such as when [[scuba diving]]) may develop a pneumothorax as a result of [[barotrauma]] from ascending just {{convert|1|m|ft|0}} while breath-holding with their lungs fully inflated.<ref name=BE2003>{{cite book |title=Bennett and Elliott's physiology and medicine of diving |edition=5th Rev |veditors=Brubakk AO, Neuman TS |year=2003 |publisher=Saunders |location=United States |isbn=978-0-7020-2571-6 | vauthors = Neuman TS |chapter=Arterial gas embolism and pulmonary barotrauma |pages=558–61}}</ref> An additional problem in these cases is that those with other features of [[decompression sickness]] are typically treated in a [[diving chamber]] with [[hyperbaric medicine|hyperbaric therapy]]; this can lead to a small pneumothorax rapidly enlarging and causing features of tension.<ref name=BE2003/> === Newborn infants === Pneumothorax is more common in neonates than in any other age group. The incidence of symptomatic neonatal is estimated to be around 1-3 per 1000 live births. Prematurity, low birth weight and asphyxia are the major risk factors, and a majority of newborn infant cases occur during the first 72 hours of life.<ref>{{Cite journal |last1=Vibede |first1=Louise |last2=Vibede |first2=Emil |last3=Bendtsen |first3=Mette |last4=Pedersen |first4=Lia |last5=Ebbesen |first5=Finn |date=2016-12-24 |title=Neonatal Pneumothorax: A Descriptive Regional Danish Study |url=http://dx.doi.org/10.1159/000453029 |journal=Neonatology |volume=111 |issue=4 |pages=303–308 |doi=10.1159/000453029 |pmid=28013308 |s2cid=4314067 |issn=1661-7800|url-access=subscription }}</ref><ref name=":0">{{cite journal | vauthors = Bruschettini M, Romantsik O, Zappettini S, O'Donnell CP, Calevo MG | title = Needle aspiration versus intercostal tube drainage for pneumothorax in the newborn | journal = The Cochrane Database of Systematic Reviews | volume = 2019 | pages = CD011724 | date = February 2019 | issue = 2 | pmid = 30707441 | pmc = 6357997 | doi = 10.1002/14651858.CD011724.pub3 }}</ref><ref name="doi.org"/> === Artificial Pneumothorax === In the late 1800s and early 1900s, physicians namely [[Carlo Forlanini]], a physician from Italy, began experimenting with intentionally collapsing the lungs of patients infected with [[tuberculosis]].<ref name=":1">{{Cite journal |last=Sakula |first=A |date=1983 |title=Carlo Forlanini, inventor of artificial pneumothorax for treatment of pulmonary tuberculosis. |url=https://pmc.ncbi.nlm.nih.gov/articles/PMC459551/?page=5 |journal=Thorax |volume=38 |issue=5 |pages=326–332. |doi=10.1136/thx.38.5.326 |pmid=6348993 |via=PubMed|pmc=459551 }}</ref> The goal of treatment was to deprive the oxygen dependent mycobacterium of the resources it requires to multiply and spread.<ref name=":1" /> Although this method fell out of common practice following the advent of pharmaceutical advancements, some research shows that in cases where medications are not effective, AP has successful results.<ref name=":2">{{Cite journal |last=Motus |first=I. Y. |last2=Skorniakov |first2=S. N. |last3=Sokolov |first3=V. A. |last4=Egorov |first4=E. A. |last5=Kildyusheva |first5=E. I. |last6=Savel'ev |first6=A. V. |last7=Zaletaeva |first7=G. E. |date=2006-05-01 |title=Reviving an old idea: can artificial pneumothorax play a role in the modern management of tuberculosis? |url=https://www.ingentaconnect.com/content/iuatld/ijtld/2006/00000010/00000005/art00017 |journal=The International Journal of Tuberculosis and Lung Disease |volume=10 |issue=5 |pages=571–577}}</ref> However, the same complications that arise with other mechanisms may still apply, leading to questions of risk vs. benefit.<ref name=":2" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)